Western Europe Medical Cannabis Market, by Application

Growth Outlook

• The Western Europe Medical Cannabis Market, by Application market is on a steady long-term growth path. Segment value stands at roughly USD 9655 Mn in 2026 and is projected to reach USD 12193 Mn by 2027 — a gain of about 26% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Hospital pharmacy leads, holding roughly 28% of segment value — the single largest regional share. Pain Management is the second-largest contributor. Neurological Health Management, Retail Pharamcy, Mental Health Management and Online Pharmacy make up the remainder, in descending order.
• By 2027, Hospital pharmacy alone is expected to reach USD 3418 Mn, with Pain Management at USD 2809 Mn.

Market Dynamics

The Western Europe medical cannabis market has been witnessing a surge in demand in recent years, thanks to the growing acceptance and legalization of medical cannabis in this region. Medical cannabis, also known as medical marijuana, refers to the use of the cannabis plant or its extracts for the treatment of various medical conditions. It contains cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), which have been found to have medicinal properties.

One of the key drivers of the demand for medical cannabis in Western Europe is the increasing number of patients opting for alternative and natural treatment methods. Medical cannabis has been found to be effective in treating a range of medical conditions, including chronic pain, epilepsy, multiple sclerosis, and cancer-related symptoms. These medicinal properties have led to a rise in demand for medical cannabis among patients who are seeking relief from their conditions.

Another factor driving the demand for medical cannabis in Western Europe is the growing number of countries legalizing its use for medical purposes. In recent years, countries like Germany, Italy, and France have legalized medical cannabis, leading to an increase in its availability and accessibility to patients. This has resulted in a growing number of patients opting for medical cannabis as a safer and more natural alternative to conventional medicines.

In addition to this, the establishment of regulatory framework and guidelines for the production, distribution, and use of medical cannabis in Western Europe has also contributed to the increasing demand. This has led to a more organized and structured market, making it easier for patients to access medical cannabis and for companies to enter and operate in the market.

Moreover, the growing awareness and acceptance of medical cannabis among healthcare professionals and the general public have also played a significant role in driving demand. As more research and studies are conducted, the evidence supporting the medicinal properties of cannabis is becoming more robust, leading to a shift in attitudes towards its use for medical purposes.

In conclusion, the demand for medical cannabis in Western Europe is expected to continue to rise in the coming years, fueled by the increasing number of patients seeking alternative treatment methods, legalization and regulation of its use, and growing awareness and acceptance among healthcare professionals and the public. As the benefits of medical cannabis become more apparent, the demand for it is only expected to further increase in Western Europe and other regions of the world.